Definium Therapeutics (DFTX) Other Working Capital Changes (2019 - 2026)
Definium Therapeutics (DFTX) reported Other Working Capital Changes of -$585000.0 for Q1 2026, down 142.39% year-over-year from $1.4 million in Q1 2025, and down 124.0% quarter-over-quarter from $2.4 million in Q4 2025.
Definium Therapeutics (DFTX) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 7 years of Other Working Capital Changes data on file, last reported at -$585000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$585000.0, down 142.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 134.23% YoY), and the FY2025 annual result was -$152000.0, down 103.5% from the prior year.
- Other Working Capital Changes eased to -$585000.0 in Q1 2026 per DFTX's latest filing, from $2.4 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.8 million in Q4 2024 and troughed at -$3.1 million in Q2 2025.
- A 5-year average of $224764.7 and a median of -$468000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes jumped 1476.85% in 2024, then slumped 309.55% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $2.1 million in 2022, then dropped by 26.75% to $1.5 million in 2023, then surged by 147.72% to $3.8 million in 2024, then sank by 35.93% to $2.4 million in 2025, then plunged by 124.0% to -$585000.0 in 2026.
- Business Quant data shows DFTX's Other Working Capital Changes at -$585000.0 in Q1 2026, $2.4 million in Q4 2025, and -$854000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -585,000.00 |
| Mar 31, 2026 | -585,000.00 |
| Dec 31, 2025 | 2.44 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | -854,000.00 |
| Sep 30, 2025 | -854,000.00 |
| Jun 30, 2025 | -3.12 Mn |
| Jun 30, 2025 | -3.12 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | -487,000.00 |
| Sep 30, 2024 | -487,000.00 |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | -468,000.00 |
| Mar 31, 2024 | -468,000.00 |
| Dec 31, 2023 | 1.54 Mn |
| Dec 31, 2023 | 1.54 Mn |